Karyopharm Therapeutics
KPTI
KPTI
157 hedge funds and large institutions have $949M invested in Karyopharm Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.45% less ownership
Funds ownership: 6.36% → 5.91% (-0.45%)
28% less capital invested
Capital invested by funds: $1.32B → $949M (-$372M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
157
Holding in Top 10
2
Calls
$7.81M
Puts
$4.85M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$13.3M | |
| 3 | +$12.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.5M |
| 5 |
BlackRock
New York
|
+$11.4M |
Top Sellers
| 1 | -$123M | |
| 2 | -$25.3M | |
| 3 | -$16.6M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$14.6M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$8.77M |